The PMHNP primarily works with older adult patients who frequently present with cognitive issues. He knows many people with Lewy body dementia are misdiagnosed or do not receive diagnosis for 18 months or more. Which of the following assessment tools does the PMHNP use to discriminate between Lewy body dementia (LBD), Parkinson's disease dementia (PDD), and mild cognitive impairment (MCI) due to Lewy body disease from other forms of cognitive impairment?
Eight-item Informant Interview to Differentiate Aging and Dementia (AD8)
Mini-Cog
Lewy Body Composite Risk Score
Informant Questionnaire on Cognitive Decline in the Elderly
The Correct Answer is C
Choice A reason: The AD8 is a brief informant interview used to detect early cognitive changes but does not specifically differentiate between LBD, PDD, and MCI due to Lewy body disease.
Choice B reason: The Mini-Cog is a screening tool for cognitive impairment but lacks specificity for Lewy body pathology.
Choice C reason: The Lewy Body Composite Risk Score is specifically designed to assess features that differentiate LBD, PDD, and MCI related to Lewy body disease from other dementias, making it the most appropriate tool.
Choice D reason: The Informant Questionnaire on Cognitive Decline in the Elderly assesses general cognitive decline but does not provide specificity for Lewy body disease subtypes.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A reason: Neurosyphilis can cause neuropsychiatric symptoms but typically presents with a broader spectrum including sensory deficits and gait disturbances.
Choice B reason: Kuru is a prion disease historically seen in Papua New Guinea with tremors and ataxia, not a common diagnosis elsewhere.
Choice C reason: Huntington’s disease presents with movement disorders (chorea), cognitive decline, and psychiatric symptoms such as depression, often in midlife.
Choice D reason: HIV-associated neurocognitive disorder may cause cognitive deficits but motor abnormalities are less specific and occur later in disease progression.
Correct Answer is D
Explanation
Choice A reason: DMARDs act on the underlying inflammatory process in rheumatoid arthritis, modifying disease progression.
Choice B reason: DMARDs slow or prevent joint damage and improve long-term functional outcomes.
Choice C reason: DMARDs are a heterogeneous group, including traditional and biologic agents, administered orally, subcutaneously, or intravenously.
Choice D reason: Symptom improvement is typically delayed and may take 6–12 weeks or longer after starting DMARD therapy; expecting improvement in 3 weeks is inaccurate.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
